Bruker (BRKR) Net Income towards Common Stockholders (2010 - 2026)
Bruker's (BRKR) quarterly Net Income towards Common Stockholders came in at $3.5 million in Q1 2026, down 79.89% YoY from $17.4 million in Q1 2025, and down 76.51% on a QoQ basis from $14.9 million in Q4 2025.
Bruker (BRKR) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Bruker (BRKR) has 17 years of Net Income towards Common Stockholders data on file, last reported at $3.5 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 79.89% year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$50.0 million (down 162.81% YoY) and the FY2025 annual result came in at -$22.5 million, down 119.89% from the prior year.
- Net Income towards Common Stockholders slipped to $3.5 million in Q1 2026, from $14.9 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $205.5 million in Q4 2023 to a low of -$62.4 million in Q3 2025.
- A 5-year average of $47.3 million and a median of $49.5 million in 2022 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders jumped 110.99% — and 2025, when it slumped 252.57%.
- Tracing BRKR's Net Income towards Common Stockholders over 5 years: stood at $97.4 million in 2022, then jumped by 110.99% to $205.5 million in 2023, then plunged by 93.33% to $13.7 million in 2024, then grew by 8.76% to $14.9 million in 2025, then tumbled by 76.51% to $3.5 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at $3.5 million (Q1 2026), $14.9 million (Q4 2025), and -$62.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Bruker | 9.21 Bn | 9.21 Bn | 416.00 Mn | -62.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -62.90 Mn |
| Mar 31, 2026 | 3.50 Mn |
| Dec 31, 2025 | 14.90 Mn |
| Sep 30, 2025 | -62.40 Mn |
| Jun 30, 2025 | -6.00 Mn |
| Mar 31, 2025 | 17.40 Mn |
| Dec 31, 2024 | 13.70 Mn |
| Sep 30, 2024 | 40.90 Mn |
| Jun 30, 2024 | 7.60 Mn |
| Mar 31, 2024 | 50.90 Mn |
| Dec 31, 2023 | 205.50 Mn |
| Sep 30, 2023 | 88.10 Mn |
| Jun 30, 2023 | 57.10 Mn |
| Mar 31, 2023 | 76.50 Mn |
| Dec 31, 2022 | 97.40 Mn |
| Sep 30, 2022 | 88.10 Mn |
| Jun 30, 2022 | 49.50 Mn |
| Mar 31, 2022 | 61.60 Mn |
| Dec 31, 2021 | 75.70 Mn |
| Sep 30, 2021 | 87.10 Mn |